Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
2 hours ago
2 hours ago
40 min
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
Module 1: MET-driven progression: Targeting the bypass
In this module, medical oncologist Dr. Julia Rotow explores the biological rationale and emerging clinical evidence behind MET amplification and overexpression as drivers of resistance following EGFR-TKI therapy in non-small cell lung cancer (NSCLC). Together with molecular pathologist Dr. Umberto Malapelle, they compare tissue and liquid biopsy approaches, including diagnostic cut-offs and thresholds used. Finally, in discussion with nurse practitioner Ms. Cathleen Power, the experts use a patient case to provide guidance on MET-directed therapy selection for patients who experience disease progression on EGFR-TKIs, managing treatment-related adverse events, and dosing considerations.
Course director:
- Dr. Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA
The experts:
- Dr. Umberto Malapelle, University of Naples Federico II, Italy
- Ms. Cathleen Power, Dana-Farber Cancer Institute, Boston, MA, USA
Module 2: Progression or evolution? Navigating the post–EGFR-TKI landscape
- Coming soon
Module 3: When actionable resistance biology is unclear: Sequencing treatment strategies after EGFR-TKI therapy
- Coming soon
Patient cases in this activity are hypothetical and are presented for educational purposes only.
This touchPODCAST is for healthcare professionals globally, outside of the UK.
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information and to claim your CME credit, visit our websites: https://touchONCOLOGYime.org/ or https://touchRESPIRATORYime.org/
7 hours ago
7 hours ago
53 min
touchCASES for touchONCOLOGY
Listen to four experts as they discuss four clinical cases illustrating optimal care for treatment-naive or previously treated patients with HER2-positive gastrointestinal cancers. They examine key decision points from biomarker testing and therapy selection to ongoing management, in patients with either biliary tract cancer or gastroesophageal adenocarcinoma.
The experts:
- Prof. Arndt Vogel, UHN Princess Margaret Cancer Centre, Toronto, Canada
- Prof. Michel Ducreux, Gustave Roussy Cancer Centre, Villejuif, France
- Prof. Florian Lordick, University Cancer Center Leipzig, Germany
- Dr. Maria Alsina Maqueda, University Hospital Navarra, Pamplona, Spain
Patient cases in this activity are hypothetical and are presented for educational purposes only.
This education is intended for medical oncologists, gastroenterologists, hepatologists, physician assistants, and oncology nurses globally, excluding the UK.
This activity is supported by an independent educational grant from Jazz Pharmaceuticals, Inc.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
7 days ago
7 days ago
14 min
touchMDT for touchONCOLOGY
Beyond tumor control: Long-term management, recurrence and survivorship in TGCT
Listen to our expert faculty explore key aspects of longitudinal tenosynovial giant cell tumor (TGCT) care, with a focus on monitoring, long-term outcomes, and optimizing care through coordinated multidisciplinary follow-up.
The multidisciplinary team
- Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA
- Medical oncologist—Prof. Dr. Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands
This touchPODCAST is for HCPs outside of the UK and Ireland only.
This activity is funded by an independent medical education grant from Merck KGaA.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.com
7 days ago
7 days ago
18 min
touchMDT for touchONCOLOGY
Beyond tumor control: Long-term multidisciplinary management of TGCT
Listen to our expert faculty explore the long-term multidisciplinary management of tenosynovial giant cell tumor (TGCT), including treatment decision-making, the CSF-1R inhibitor landscape, and regional care differences across the USA, Europe, and China.
The multidisciplinary team
- Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA
- Medical oncologist—Prof. Dr. Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands
- Orthopedic oncologist—Prof. Xiaohui Niu, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China
This touchPODCAST is for HCPs outside of the UK and Ireland only.
This activity is funded by an independent medical education grant from Merck KGaA.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.com
7 days ago
7 days ago
15 min
touchMDT for touchONCOLOGY
Recognizing TGCT earlier: Improving clinical recognition
Listen to our expert faculty explore key clinical features and imaging hallmarks of tenosynovial giant cell tumor (TGCT), focusing on clinical red flags, differential diagnoses, and timely referral pathways to specialist sarcoma multidisciplinary teams.
The multidisciplinary team
- Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA
- Orthopedic surgeon—Dr. Brian Brigman, Duke Cancer Center, Durham, NC, USA
This touchPODCAST is for HCPs outside of the UK and Ireland only.
This activity is funded by an independent medical education grant from Merck KGaA.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.com
Oct 29, 2026
Oct 29, 2026
18 min
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen as Dr. Karolinne Rocha shares her insights on the clinical, diagnostic, and patient-specific factors that shape presbyopia-correcting intraocular lens (PCIOL) selection. She also discusses how shared decision-making and counseling can align patient expectations with likely outcomes, including in patients with previous refractive surgery.
The expert:
- Dr. Karolinne Rocha, Medical University of South Carolina, Storm Eye Institute, Charleston, SC, USA
This touchPODCAST is for HCPs outside of the UK.
This educational activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Oct 29, 2026
Oct 29, 2026
32 min
touchEXPERT FOCUS for touchONCOLOGY
Dr. Sara Tolaney, a leading breast medical oncologist, shares insights into the distinct toxicity profiles of antibody–drug conjugates (ADCs) approved for metastatic breast cancer (mBC). She explores practical approaches for monitoring, recognizing, and diagnosing ADC-related side effects, and discusses evidence-based strategies for managing treatment-related toxicities. She also provides guidance to support timely intervention to optimize the care of patients with mBC receiving ADCs.
The experts
- Dr. Sara Tolaney, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
Oct 22, 2026
Oct 22, 2026
34 min
touchEXPERT FOCUS for touchENDOCRINOLOGY
Listen to a series of interviews with Dr. Sheila Mody who will provide her expert insights into oral and nonoral hormonal contraceptive options, guidance on correct use of transdermal patches and strategies to support shared decision-making in selection of hormonal contraceptives.
The expert:
- Dr. Sheila Mody based in San Diego, CA, USA
This touchPODCAST is for HCPs in the USA only.
This program is supported in part by:
An independent medical educational grant from Mylan Inc., a Viatris Company.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
For further information visit our website: www.touchENDOCRINOLOGY.com
Oct 21, 2026
Oct 21, 2026
38 min
touchEXPERT FOCUS for touchENDOCRINOLOGY and touchHEPATOLOGY
Hear from our expert faculty as they share insights into the pathophysiology, treatment, and multidisciplinary management of glycogen storage disease type Ia (GSDIa). This series of short interviews explores the clinical manifestations of the disorder and highlights how day-to-day standard of care requires a coordinated, multidisciplinary approach.
The experts:
- Dr. Deeksha Bali, Duke University Medical Center, Durham, NC, USA
- Dr David Rodriguez-Buritica, The University of Texas Health Science Center at Houston (UTHealth Houston), TX, USA
- Dr. Kadakkal Radhakrishnan, Cleveland Clinic, OH, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Ultragenyx Pharmaceutical Inc.
The activity is jointly provided by USF Health and touchIME.
For further information, please visit our websites: www.touchENDOCRINOLOGY.com and www.touchHEPATOLOGY.com
Oct 20, 2026
Oct 20, 2026
16 min
Listen to our expert faculty discuss multidisciplinary care for cardiac amyloidosis, including referral pathways, coordinated treatment decisions and collaboration between specialist centers and local care teams. They also explore monitoring and follow-up for cardiac amyloidosis.
The multidisciplinary team:
- Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria
- Hematologist – Dr. Yawara Kawano, Kumamoto University Hospital, Kumamoto City, Japan
- Amyloidosis specialist with a renal focus – Dr. Paolo Milani, University of Pavia, Pavia, Italy
- Amyloidosis MDT nurse/coordinator – Ms. Christine Chiti, Royal Free London NHS Foundation Trust, London, UK
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is supported by an independent medical education grant from Alexion Pharma GmbH.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.
For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY
